Pacific Biosciences Of California Shares Outstanding 2009-2018 | PACB

Pacific Biosciences Of California shares outstanding from 2009 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Pacific Biosciences Of California Annual Shares Outstanding
(Millions of Shares)
2017 106
2016 89
2015 76
2014 70
2013 63
2012 56
2011 54
2010 10
2009 1
2008 0
2007 0
Pacific Biosciences Of California Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 135
Q2 2018 132
Q1 2018 124
Q4 2017 106
Q3 2017 116
Q2 2017 97
Q1 2017 93
Q4 2016 89
Q3 2016 92
Q2 2016 88
Q1 2016 84
Q4 2015 76
Q3 2015 80
Q2 2015 75
Q1 2015 74
Q4 2014 70
Q3 2014 71
Q2 2014 71
Q1 2014 68
Q4 2013 63
Q3 2013 66
Q2 2013 62
Q1 2013 57
Q4 2012 56
Q3 2012 56
Q2 2012 56
Q1 2012 55
Q4 2011 54
Q3 2011 54
Q2 2011 53
Q1 2011 53
Q4 2010 10
Q3 2010 1
Q2 2010 1
Q1 2010 1
Q4 2009 0
Q3 2009 1
Q4 2008 0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.121B $0.093B
Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $94.952B 22.13
Intuitive Surgical (ISRG) United States $56.151B 55.25
Edwards Lifesciences (EW) United States $32.865B 35.17
Fresenius Medical Care AG KGaA (FMS) Germany $21.890B 14.80
IDEXX Laboratories (IDXX) United States $16.385B 46.80
ABIOMED (ABMD) United States $14.301B 102.76
Hologic (HOLX) United States $12.141B 18.74
Teleflex (TFX) United States $11.801B 26.79
Varian Medical Systems (VAR) United States $10.826B 26.94
DexCom (DXCM) United States $10.787B 0.00
STERIS (STE) United Kingdom $9.628B 25.55
Masimo (MASI) United States $5.580B 36.19
LivaNova (LIVN) United Kingdom $4.617B 29.64
Penumbra (PEN) United States $4.545B 274.42
Globus Medical (GMED) United States $4.509B 28.26
Integra LifeSciences Holdings (IART) United States $4.256B 20.73
Cantel Medical (CMD) United States $3.351B 33.05
Wright Medical Group (WMGI) Netherlands $3.313B 0.00
Inogen (INGN) United States $2.966B 64.02
Integer Holdings (ITGR) United States $2.712B 22.70
Glaukos (GKOS) United States $2.247B 0.00
Halyard Health (AVNS) United States $2.186B 19.70
Tandem Diabetes Care (TNDM) United States $1.921B 0.00
OPKO Health (OPK) United States $1.836B 0.00
Mazor Robotics (MZOR) Israel $1.532B 0.00
Luminex (LMNX) United States $1.267B 45.84
Nevro (NVRO) United States $1.250B 0.00
AxoGen (AXGN) United States $1.137B 0.00
Natus Medical (BABY) United States $1.133B 23.79
Orthofix (OFIX) United States $1.066B 30.78
CryoLife (CRY) United States $1.057B 92.19
Tactile Systems Technology (TCMD) United States $0.988B 157.38
Intersect ENT (XENT) United States $0.940B 0.00
Mesa Laboratories (MLAB) United States $0.815B 48.19
AngioDynamics (ANGO) United States $0.771B 26.99
Accelerate Diagnostics (AXDX) United States $0.767B 0.00
ViewRay (VRAY) United States $0.603B 0.00
SI-BONE INC (SIBN) United States $0.494B 0.00
Sientra (SIEN) United States $0.493B 0.00
Veracyte (VCYT) United States $0.483B 0.00
OrthoPediatrics (KIDS) United States $0.424B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.395B 0.00
Quotient (QTNT) Switzerland $0.361B 0.00
Neuronetics (STIM) United States $0.346B 0.00
Accuray (ARAY) United States $0.334B 0.00
SeaSpine Holdings (SPNE) United States $0.319B 0.00
Nuvectra (NVTR) United States $0.316B 0.00
Fluidigm (FLDM) United States $0.309B 0.00
GenMark Diagnostics (GNMK) United States $0.281B 0.00
IRadimed (IRMD) United States $0.278B 72.57
RTI Surgical (RTIX) United States $0.242B 38.20
Helius Medical Technologies (HSDT) United States $0.234B 0.00
Pulse Biosciences (PLSE) United States $0.219B 0.00
T2 Biosystems (TTOO) United States $0.184B 0.00
Ra Medical Systems (RMED) United States $0.115B 0.00
Alphatec Holdings (ATEC) United States $0.113B 0.00
Ekso Bionics Holdings (EKSO) United States $0.111B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.094B 0.00
Sensus Healthcare (SRTS) United States $0.089B 0.00
Apollo Endosurgery (APEN) United States $0.088B 0.00
Second Sight Medical Products (EYES) United States $0.077B 0.00
EDAP TMS (EDAP) France $0.075B 0.00
Biosig Technologies (BSGM) United States $0.065B 0.00
Restoration Robotics (HAIR) United States $0.045B 0.00
Viveve Medical (VIVE) United States $0.043B 0.00
OBALON THERPTCS (OBLN) United States $0.041B 0.00
Vermillion (VRML) United States $0.039B 0.00
ConforMIS (CFMS) United States $0.032B 0.00
Lianluo Smart (LLIT) China $0.028B 0.00
PAVmed (PAVM) United States $0.027B 0.00
Titan Medical (TMDI) Canada $0.025B 0.00
Dynatronics (DYNT) United States $0.021B 0.00
DarioHealth (DRIO) Israel $0.020B 0.00
Neovasc (NVCN) Canada $0.018B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
Bioanalytical Systems (BASI) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Presbia (LENS) Ireland $0.011B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Avinger (AVGR) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
ReWalk Robotics (RWLK) Israel $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Microbot Medical (MBOT) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.006B 0.00
Amedica (SINT) United States $0.005B 0.00
EnteroMedics (RSLS) United States $0.001B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00